RT Journal Article
SR Electronic
T1 Cimetidine
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 29
OP 32
DO 10.1136/dtb.17.8.29
VO 17
IS 8
YR 1979
UL http://dtb.bmj.com/content/17/8/29.abstract
AB Cimetidine (Tagamet - SKF) is the first histamine-H2 receptor antagonist in general use. It reduces gastric acid secretion and is marketed for the treatment of duodenal ulcer, benign gastric ulcer, recurrent and stomal ulceration, reflux oesophagitis and Zollinger-Ellison syndrome.